October 19, 2018 / 4:20 PM / 25 days ago

BRIEF-FDA Approves Label Update For Genentech's Rituxan

Oct 19 (Reuters) - Genentech:

* FDA APPROVES LABEL UPDATE FOR GENENTECH’S RITUXAN (RITUXIMAB) IN TWO RARE FORMS OF VASCULITIS

* GENENTECH - RITUXAN LABEL UPDATED TO INCLUDE INFORMATION FOR PATIENTS WITH 2 RARE VASCULITIS FORMS HAVING ACHIEVED DISEASE CONTROL WITH INDUCTION TREATMENT

* GENENTECH - PRECAUTION ON LIMITED DATA AVAILABILITY, NON-ESTABLISHMENT OF RITUXAN RETREATMENT SAFETY, EFFICACY REMOVED FROM RITUXAN PRESCRIBING INFORMATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below